EUVIMEDEUVIMED entdecken
Crossref

Untargeted Metabolomic Analysis of Exhaled Breath Condensate Identifies Disease‐Specific Signatures in Adults With Asthma

Hongfei Zhao, Yujuan Yang, Yan Hao, Wenbin Zhang, Limei Cui, Jianwei Wang, Ying Chen, Ting Zuo, Hang Yu, Yu Zhang, Xicheng Song iD

Clinical & Experimental Allergy · 2025

DOI: 10.1111/cea.70059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2025. Verfasst von Hongfei Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Medical College, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Asthma, Metabolomics, Exhalation, Metabolome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Major Scientific and Technological Innovation Project of Shandong Province, Medical and Health Science and Technology Development Program of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

An objective test for the auxiliary diagnosis of asthma is still lacking. The aim of this study was to discriminate asthma signatures via an untargeted metabolomic analysis of exhaled breath condensate. Materials and Methods This study enrolled 19 patients diagnosed with asthma and 23 healthy volunteers. Samples of exhaled breath condensate (EBC) were collected from both groups. Untargeted metabolomic analyses of EBC were used to identify disease‐specific signatures for asthma.

Result

There were 30 identifiable differentially expressed metabolites and 7 disordered metabolic pathways between the EBCs of asthmatic patients and healthy control subjects. The main differential pathways included biosynthesis of unsaturated fatty acids, HIF‐1 signalling pathway, Glutathione metabolism, Ascorbate and aldarate metabolism, and fatty acid biosynthesis. The integrated machine learning method was used to construct an asthma EBC metabolomic signature model from four differential metabolites; 3,4′‐dimethoxy‐2′‐hydroxychalcone, C17‐sphinganine, (z)‐6‐octadecenoic acid, and 2‐butylaniline. The model showed a high level of discrimination efficiency (area under curve (AUC) = 0.98), with robust validation through logistic regression (LR), random forest (RF), and support vector machine (SVM) (LR AUC = 0.98, RF AUC = 0.94, SVM AUC = 1.00). The discriminative ability of the EBC metabolomic signature model in both the training set (AUC = 1.0) and testing data (AUC = 0.817) was superior to that of FeNO (AUC = 0.515 and 0.567, respectively) and FEV1/FVC % predicted (AUC = 0.767 and 0.765, respectively). Among the four biomarkers, (z)‐6‐octadecenoic acid was significantly correlated with serum IgE.

Conclusion

The EBC metabolomic signature model demonstrated good feasibility for assisting in the diagnosis of asthma in adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaMetabolomicsExhalationMetabolomeHumansMaleFemaleAdultBreath TestsMiddle AgedBiomarkers

Stichwörter der Autor:innen

asthmabiomarkerexhaled breath condensatemetabolomic signature modelmetabolomics analysis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Qingdao Medical College, Qingdao University, Qingdao, China.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
  • Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai, Shandong, China.
  • Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Second Clinical Medicine College, Binzhou Medical University, Yantai, Shandong, China.

ORCID-Profile: Xicheng Song

Förderung

  • National Natural Science Foundation of China
  • Major Scientific and Technological Innovation Project of Shandong Province
  • Medical and Health Science and Technology Development Program of Shandong Province

Zitieren

APA

Zhao, H., Yang, Y., Hao, Y., Zhang, W., Cui, L., Wang, J., Chen, Y., Zuo, T., Yu, H., Zhang, Y., & Song, X. (2025). Untargeted Metabolomic Analysis of Exhaled Breath Condensate Identifies Disease‐Specific Signatures in Adults With Asthma. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70059

Vancouver

Zhao H, Yang Y, Hao Y, Zhang W, Cui L, Wang J, et al. Untargeted Metabolomic Analysis of Exhaled Breath Condensate Identifies Disease‐Specific Signatures in Adults With Asthma. Clinical & Experimental Allergy. 2025. doi:10.1111/cea.70059

BibTeX
@article{Zhao2025,
  author = {Zhao, Hongfei and Yang, Yujuan and Hao, Yan and Zhang, Wenbin and Cui, Limei and Wang, Jianwei and Chen, Ying and Zuo, Ting and Yu, Hang and Zhang, Yu and Song, Xicheng},
  title = {Untargeted Metabolomic Analysis of Exhaled Breath Condensate Identifies Disease‐Specific Signatures in Adults With Asthma},
  journal = {Clinical & Experimental Allergy},
  year = {2025},
  doi = {10.1111/cea.70059}
}
Kostenlos starten →